Drugs for Alzheimer's Disease: Are They Effective?

Overview

Journal P T

Specialty Pharmacology

Date 2010 May 26

PMID 20498822

Citations 106

Authors

David A Casey

Demetra Antimisiaris

James OBrien

Affiliations

Soon will be listed here.

Citing Articles

Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice.

Takomthong P, Waiwut P, Yenjai C, Wangboonskul J, Plekratoke K, Arsito P PLoS One. 2025; 20(3):e0316888.

PMID: 40063637 PMC: 11892870. DOI: 10.1371/journal.pone.0316888.

Stacked CNN-based multichannel attention networks for Alzheimer disease detection.

Hassan N, Miah A, Suzuki K, Okuyama Y, Shin J Sci Rep. 2025; 15(1):5815.

PMID: 39962097 PMC: 11832778. DOI: 10.1038/s41598-025-85703-x.

Nanotherapeutic smart approaches for combating Alzheimer's disease and overcoming existing obstacles: A novel eco-friendly green approach.

Almehdi A, Aboubaker D, Hamdy R, El-Keblawy A Toxicol Rep. 2025; 14:101906.

PMID: 39926413 PMC: 11803169. DOI: 10.1016/j.toxrep.2025.101906.

Smart Driving Technology for Non-Invasive Detection of Age-Related Cognitive Decline.

Serhan P, Victor S, Osorio Perez O, Abi Karam K, Elghoul A, Ransdell M Sensors (Basel). 2025; 24(24.

PMID: 39771798 PMC: 11679439. DOI: 10.3390/s24248062.

Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review.

Izadi R, Bahramikia S, Akbari V Front Neurosci. 2024; 18:1453499.

PMID: 39649663 PMC: 11621856. DOI: 10.3389/fnins.2024.1453499.

References

Winblad B, Poritis N . Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry. 2000; 14(2):135-46. DOI: 10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0. View

Howard R, Juszczak E, Ballard C, Bentham P, Brown R, Bullock R . Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med. 2007; 357(14):1382-92. DOI: 10.1056/NEJMoa066583. View

Gilstad J, Finucane T . Results, rhetoric, and randomized trials: the case of donepezil. J Am Geriatr Soc. 2008; 56(8):1556-62. DOI: 10.1111/j.1532-5415.2008.01844.x. View

Birks J . Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006; (1):CD005593. PMC: 9006343. DOI: 10.1002/14651858.CD005593. View

Rabins P, Blacker D, Rovner B, Rummans T, Schneider L, Tariot P . American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry. 2008; 164(12 Suppl):5-56. View

Birks J, Harvey R . Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev. 2006; (1):CD001190. DOI: 10.1002/14651858.CD001190.pub2. View

Qaseem A, Snow V, Cross Jr J, Forciea M, Hopkins Jr R, Shekelle P . Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008; 148(5):370-8. DOI: 10.7326/0003-4819-148-5-200803040-00008. View

Geldmacher D, Provenzano G, McRae T, Mastey V, Ieni J . Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. J Am Geriatr Soc. 2003; 51(7):937-44. DOI: 10.1046/j.1365-2389.2003.51306.x. View

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

10.

Areosa S, Sherriff F, McShane R . Memantine for dementia. Cochrane Database Syst Rev. 2005; (2):CD003154. DOI: 10.1002/14651858.CD003154.pub3. View

11.

Tariot P, Farlow M, Grossberg G, Graham S, McDonald S, Gergel I . Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004; 291(3):317-24. DOI: 10.1001/jama.291.3.317. View

12.

Orgogozo J, Rigaud A, Stoffler A, Forette F . Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke. 2002; 33(7):1834-9. DOI: 10.1161/01.str.0000020094.08790.49. View

13.

Knopman D, KNAPP M, Gracon S, Davis C . The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. Neurology. 1994; 44(12):2315-21. DOI: 10.1212/wnl.44.12.2315. View

14.

Warner J, Butler R . Drugs for Alzheimer's disease. More effective agents are needed. BMJ. 2001; 323(7321):1127-8. PMC: 1121609. View

15.

Jackson S, Ham R, Wilkinson D . The safety and tolerability of donepezil in patients with Alzheimer's disease. Br J Clin Pharmacol. 2004; 58 Suppl 1:1-8. PMC: 1884556. DOI: 10.1111/j.1365-2125.2004.01848.x. View

16.

ROSEN W, Mohs R, Davis K . A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984; 141(11):1356-64. DOI: 10.1176/ajp.141.11.1356. View

17.

Cummings J, Mega M, Gray K, Carusi D, Gornbein J . The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12):2308-14. DOI: 10.1212/wnl.44.12.2308. View

18.

Molnar F, Hutton B, Fergusson D . Does analysis using "last observation carried forward" introduce bias in dementia research?. CMAJ. 2008; 179(8):751-3. PMC: 2553855. DOI: 10.1503/cmaj.080820. View

19.

Larson E, Shadlen M, Wang L, McCormick W, Bowen J, Teri L . Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004; 140(7):501-9. DOI: 10.7326/0003-4819-140-7-200404060-00008. View

20.

Mount C, Downton C . Alzheimer disease: progress or profit?. Nat Med. 2006; 12(7):780-4. DOI: 10.1038/nm0706-780. View